Alkermes Announces Advances in Late-Stage CNS Pipeline
January 08, 2014 at 07:02 AM EST
Alkermes (NASDAQ: ALKS ) today announced new developments related to its late-stage product candidates in its proprietary central nervous system (CNS) pipeline. The company unveiled aripiprazole lauroxil two-month, a
